Full-Time

R&D Director

Polymer Materials Development

Posted on 7/2/2025

Deadline 8/31/25
Alcon

Alcon

10,001+ employees

Specializes in eye care products and solutions

No salary listed

Expert

Frankfurt, Germany

In Person

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Polymer Chemistry, Organic Chemistry, Material Sciences or related field is required with min. 10 years of post-graduated experience
  • Experience in Polymer synthesis and Characterization is highly preferred
  • The ability to fluently read, write, understand and communicate in English
  • Prior experience working in medical device field and regulated laboratory setting per GLP/GDP requirements is preferred
Responsibilities
  • Demonstrating scientific leadership by applying scientific/technical expertise and setting standards for the lens materials and chemical processes related scientific work, ensuring the quality and integrity of the research outputs
  • Developing concepts and proposing approach to address identified ophthalmic medical device/science/technology need
  • Developing new materials based on in-depth understanding in both material technology and production process
  • Participating in sub-teams, use deep technical/scientific knowledge to advise and contribute to all function strategies and goals
  • Assisting management of project activities, support/coach and laterally lead scientists, researchers, and technicians, foster a collaborative and innovative culture but no formal disciplinary management tasks
  • Working closely with internal production or external vendors to scale-up new products
  • Providing answers to ad hoc questions and demonstrating an in-depth understanding of structure-property-process relationship in polymers, specifically the relationship between molecular architecture, morphology, and bulk properties
  • Developing an external network of research partners and collaborators to complement internal competencies in the above-mentioned research areas. Actively monitoring patent and scientific literature for significant technical developments relevant to eye care products
Desired Qualifications
  • Experience in Polymer synthesis and Characterization is highly preferred
  • Prior experience working in medical device field and regulated laboratory setting per GLP/GDP requirements is preferred

Alcon specializes in eye care products and vision solutions aimed at improving people's quality of life through better vision. Their product offerings include solutions for cataract surgery, retinal health, and contact lenses. Alcon's products work by utilizing advanced technology and research to provide effective treatments and products for eye care professionals and consumers. What sets Alcon apart from its competitors is its strong emphasis on research and development, ensuring they remain leaders in the eye care industry. The company's goal is to enhance vision and overall quality of life while promoting a diverse and inclusive workplace.

Company Size

10,001+

Company Stage

IPO

Headquarters

Geneva, Switzerland

Founded

1945

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing myopia prevalence boosts demand for Alcon's innovative contact lens solutions.
  • FDA approval of Acoltremon Ophthalmic Solution expands Alcon's product portfolio for dry eye disease.
  • Digital health trends offer Alcon opportunities to integrate advanced tools into eye care.

What critics are saying

  • Increased competition from emerging companies may impact Alcon's market share.
  • Patent litigation with Padagis Israel Pharms. Ltd. could lead to financial liabilities.
  • LumiThera acquisition may face integration challenges, affecting operational efficiency.

What makes Alcon unique

  • Alcon leads in eye care with innovative cataract and retinal health solutions.
  • Their commitment to diversity and inclusion strengthens their corporate culture and values.
  • Alcon's strategic acquisitions, like LumiThera, enhance their product offerings and market position.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

HSA Medical Plan

PTO

Paid Parental leave

401k

Retirement Plan Company Contribution

Low payroll deductions

Tuition Reimbursement Program

Annual Bonus

Free Family Contact Lens Program

12 Company Paid Holidays

Company News

Opti-Guide
Jul 8th, 2025
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

Alcon announced its intention to acquire LumiThera and its PBM device for the treatment of early and intermediate dry AMD.

Optics.org
Jul 8th, 2025
Alcon snaps up LumiThera for light-based AMD treatment

Alcon, the Geneva-headquartered eyecare company, has announced plans to acquire LumiThera, a US firm that is working on a multi-wavelength treatment for dry age-related macular degeneration (AMD).

Alcon
Jul 8th, 2025
Alcon Names Julie M. Brewer to its Executive Leadership Team as SVP, President, Global Franchises

FORT WORTH, July 8, 2025 - Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Julie M. Brewer will join the company and its Executive Leadership Team as Senior Vice President, President, Global Franchises, effective July 9.

Ophthalmology Times
Jul 7th, 2025
Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

Alcon is continuing its trend of acquisitions in 2025 with the recent announcement that the company will acquire LumiThera, Inc. and its photobiomodulation (PBM) device for the treatment of early and intermediate dry age-related macular degeneration (AMD).

HCPLive
May 29th, 2025
FDA Approves Acoltremon Ophthalmic Solution (TRYPTYR) for Dry Eye Disease

Alcon has also announced its intention to launch acoltremon ophthalmic solution in the US during the third quarter of 2025 and anticipates bringing it to other markets in the future.

INACTIVE